Delivery Order SPE2DB22D3301-SPE2DB25FY2WX

Award Date 4/8/25
Potential Completion Date 4/29/25
Potential Value $52K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is for the delivery of OFEV 150 MG capsules. The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $8,590.58 and an ultimate completion date of May 5, 2025. The contract covers the procurement of OFEV 150 MG capsules, a specialty pharmaceutical product. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $25,771.74, is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This federal contract award, valued at $23,726.96, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OFEV 150 MG capsule pharmaceutical product, with a completion date of July 24, 2024. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,630.28, is for the delivery of OFEV 100 MG CAPSULE 60S, a specialty pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award, valued at $7,905.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OFEV 150 MG CAPSULE 60S, a medical product, with a completion date of November 15, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,590.58, is a delivery order for the supply of OFEV 150 MG capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,771.74 and a period of performance through April 11, 2025. The contract is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,771.74 Firm Fixed Price Delivery Order contract is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide OFEV 150 mg capsules (60 count). The award has a ceiling value of $31,622.24 and an ultimate completion date of October 1, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY2WX
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $51,543.48, is for the delivery of OFEV 150 MG capsules.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The contract has a firm fixed price pricing type and an ultimate completion date of April 29, 2025.

Generated 7/8/25, 2:23 PM